Connecting minds.
Enhancing the future.
Synaption Neurotechnology is building AI-powered diagnostic tools that support clinicians in neurological and psychiatric assessment, making advanced neurotechnology accessible, transparent, and clinically meaningful.
Why We Exist
Over a billion people worldwide live with neurological or psychiatric conditions, yet diagnosis still depends largely on subjective clinical interviews. Meanwhile, EEG has been recording brain electrical activity for nearly a century. The data is there. The tools to use it clinically are not.
SynapCore turns that raw signal into structured, clinician-ready decision support. It does not replace professional judgement. It gives clinicians something they have never had: an objective, data-driven second opinion grounded in the patient's own brain activity.
"Synaption does NOT replace the professional. It empowers them."
Meet the Founder
Joan
Founder & CEO
Trained in Biomedical Engineering (BEng, Middlesex University London) with postgraduate studies in Neurotechnology at Imperial College London. Years of hands-on work with EEG signal processing and machine learning for neural data shaped a clear conviction: the gap between EEG research and clinical practice is too wide.
Synaption exists to close that gap. Not with another paper, but with a tool clinicians can actually use.
Corporate Structure
Synaption Neurotechnology Ltd
ActiveUnited Kingdom. Incorporated entity. Primary legal and operational entity for regulatory submissions, IP ownership, and commercial activities.
Synaption Neurotechnology SL
In ProgressSpain, incorporation in progress. European operational entity for EU market access and local operations.
Regulatory Commitment
Patient safety is non-negotiable. Synaption is pursuing full regulatory compliance through IEC 62304 software lifecycle management, targeting CE Mark Class IIa, UKCA, and FDA 510(k) clearance before any clinical deployment. We will not release a product until it meets the highest safety and efficacy standards.
What We Stand For
Scientific Rigour
We validate with LOSO cross-validation because it is the hardest test, not the most flattering. We report AUC 0.845, not a cherry-picked k-fold score. Every metric on this site can be reproduced from public data.
Transparency
Our datasets are public. Our methodology is documented. Our limitations are stated on every page. When we do not know something, we say so. Trust is not claimed; it is earned through openness.
Accessibility
A rural clinic and a London teaching hospital should have access to the same diagnostic intelligence. We are building SynapCore so that advanced EEG analysis is not limited by geography or budget.